Brought to you by 
Curtin Matheson gets US rights to Biosite Triage; ends
01 Dec 2009
Executive Summary
Curtin Matheson Scientific licensed exclusive US rights to sell Biosite's (point-of-care tests) Triage DOA drugs of abuse tests to hospitals, non-industrial laboratories, and certain other medical facilities.
Deal Industry
- In Vitro Diagnostics
-
In Vitro Diagnostics
- Chemistry, Immunoassay
Deal Status
- Terminated
Deal Type
-
Alliance
- Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Curtin Matheson gets US rights to Biosite Triage; ends
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice